{
  "items": "50",
  "sentiment_score_definition": "x <= -0.35: Bearish; -0.35 < x <= -0.15: Somewhat-Bearish; -0.15 < x < 0.15: Neutral; 0.15 <= x < 0.35: Somewhat_Bullish; x >= 0.35: Bullish",
  "relevance_score_definition": "0 < x <= 1, with a higher score indicating higher relevance.",
  "feed": [
    {
      "title": "Clarivate Launches Agentic AI Assistant for Life Sciences Regulatory Compliance to Streamline Global Safety Workflows",
      "url": "https://finviz.com/news/263084/clarivate-launches-agentic-ai-assistant-for-life-sciences-regulatory-compliance-to-streamline-global-safety-workflows",
      "time_published": "20251228T124600",
      "authors": [
        "Maham Fatima"
      ],
      "summary": "Clarivate has introduced its Cortellis Regulatory Intelligence AI Assistant, an agentic AI-powered tool designed to streamline global safety workflows in life sciences. This assistant streamlines regulatory compliance by allowing users to ask complex questions in natural language, summarize documents, and compare guidance documents, thereby saving significant manual labor and accelerating decision-making throughout the product lifecycle. The tool leverages Clarivate\u2019s established AI platform and over 30 years of regulatory expertise, aiming to transform how regulatory teams interpret global requirements into actionable insights.",
      "banner_image": "https://d2gr5kl7dt2z3t.cloudfront.net/blog/wp-content/uploads/2023/09/29140348/CLVT-insidermonkey-1696010626137.jpg",
      "source": "Finviz",
      "category_within_source": "General",
      "source_domain": "Finviz",
      "topics": [
        {
          "topic": "life_sciences",
          "relevance_score": "1.000000"
        },
        {
          "topic": "technology",
          "relevance_score": "0.907734"
        },
        {
          "topic": "financial_markets",
          "relevance_score": "0.743218"
        },
        {
          "topic": "earnings",
          "relevance_score": "0.611296"
        },
        {
          "topic": "finance",
          "relevance_score": "0.625103"
        }
      ],
      "overall_sentiment_score": 0.418331,
      "overall_sentiment_label": "Bullish",
      "ticker_sentiment": [
        {
          "ticker": "CLVT",
          "relevance_score": "0.968227",
          "ticker_sentiment_score": "0.401236",
          "ticker_sentiment_label": "Bullish"
        }
      ]
    },
    {
      "title": "Clarivate (NYSE:CLVT) Stock Rating Lowered by Wall Street Zen",
      "url": "https://www.marketbeat.com/instant-alerts/clarivate-nyseclvt-stock-rating-lowered-by-wall-street-zen-2025-12-27/",
      "time_published": "20251227T060916",
      "authors": [
        "MarketBeat"
      ],
      "summary": "Clarivate (NYSE:CLVT) has been downgraded by Wall Street Zen from a \"buy\" to a \"hold\" rating, resulting in a new consensus rating of \"Reduce\" with a target price of $4.43. Despite the downgrade, significant insider buying has been noted, with directors acquiring millions of shares in recent months. The company's stock opened at $3.52 and maintains a market capitalization of $2.32 billion.",
      "banner_image": "https://www.marketbeat.com/logos/clarivate-plc-logo-1200x675.png?v=20210319144346",
      "source": "MarketBeat",
      "category_within_source": "General",
      "source_domain": "MarketBeat",
      "topics": [
        {
          "topic": "financial_markets",
          "relevance_score": "0.901560"
        },
        {
          "topic": "finance",
          "relevance_score": "0.812692"
        },
        {
          "topic": "life_sciences",
          "relevance_score": "0.608112"
        },
        {
          "topic": "technology",
          "relevance_score": "0.628895"
        }
      ],
      "overall_sentiment_score": -0.204838,
      "overall_sentiment_label": "Somewhat-Bearish",
      "ticker_sentiment": [
        {
          "ticker": "CLVT",
          "relevance_score": "1.000000",
          "ticker_sentiment_score": "-0.222296",
          "ticker_sentiment_label": "Somewhat-Bearish"
        }
      ]
    },
    {
      "title": "Accelerate FTO & Patent Monitoring | Derwent Patent Monitor",
      "url": "https://clarivate.com/intellectual-property/blog/streamline-fto-reviews-and-patent-monitoring-with-derwent-patent-monitor/",
      "time_published": "20251222T091024",
      "authors": [],
      "summary": "Derwent Patent Monitor is a new software solution designed to streamline Freedom to Operate (FTO) reviews and patent monitoring, eliminating fragmentation and improving risk management. It utilizes AI-powered threat analysis, project-based workflows, and integration with other Clarivate tools to accelerate decision-making and provide a clear audit trail. This solution aims to address the shortcomings of traditional manual patent monitoring methods by enhancing visibility, prioritization, and auditability.",
      "banner_image": "https://clarivate.com/intellectual-property/wp-content/uploads/sites/5/2025/12/CL_photo_abstract_150-1-scaled.jpg",
      "source": "Clarivate",
      "category_within_source": "General",
      "source_domain": "Clarivate",
      "topics": [
        {
          "topic": "technology",
          "relevance_score": "0.825592"
        }
      ],
      "overall_sentiment_score": 0.440579,
      "overall_sentiment_label": "Bullish",
      "ticker_sentiment": [
        {
          "ticker": "CLVT",
          "relevance_score": "1.000000",
          "ticker_sentiment_score": "0.445232",
          "ticker_sentiment_label": "Bullish"
        }
      ]
    },
    {
      "title": "Clarivate Plc (CLVT) Downgraded Amid Turnaround Challenges",
      "url": "https://www.insidermonkey.com/blog/clarivate-plc-clvt-downgraded-amid-turnaround-challenges-1663473/?amp=1",
      "time_published": "20251221T074000",
      "authors": [
        "Rameen Kasana"
      ],
      "summary": "Morgan Stanley downgraded Clarivate Plc (CLVT) to Underweight and lowered its price target to $3, citing the company's struggling turnaround efforts, flat-to-low-single-digit growth guidance, and limited operating leverage. The firm also noted funding pressures in key sectors and increasing competitive pressure from AI. This contrasts with RBC Capital's earlier \"Buy\" rating and $5 price target, resulting in mixed analyst sentiment for CLVT.",
      "banner_image": "NULL",
      "source": "Insider Monkey",
      "category_within_source": "General",
      "source_domain": "Insider Monkey",
      "topics": [
        {
          "topic": "earnings",
          "relevance_score": "0.915250"
        },
        {
          "topic": "financial_markets",
          "relevance_score": "0.808917"
        },
        {
          "topic": "life_sciences",
          "relevance_score": "0.625876"
        },
        {
          "topic": "technology",
          "relevance_score": "0.642935"
        }
      ],
      "overall_sentiment_score": -0.271892,
      "overall_sentiment_label": "Somewhat-Bearish",
      "ticker_sentiment": [
        {
          "ticker": "CLVT",
          "relevance_score": "1.000000",
          "ticker_sentiment_score": "-0.290491",
          "ticker_sentiment_label": "Somewhat-Bearish"
        }
      ]
    },
    {
      "title": "Nissan Selects IPfolio from Clarivate",
      "url": "https://martechseries.com/technology/nissan-selects-ipfolio-from-clarivate/",
      "time_published": "20251219T010924",
      "authors": [
        "PRNewswire"
      ],
      "summary": "Nissan Motor Co., Ltd. has chosen Clarivate's IPfolio for its intellectual property management software. This will enable Nissan to manage and protect its IP more efficiently through advanced workflow automation and leading data and analytics. The implementation aims to establish a scalable IPMS, enhance data visibility, and integrate with other data sources.",
      "banner_image": "https://martechseries.com/wp-content/uploads/2025/12/Nissan-Selects-IPfolio-from-Clarivate-1068x604.jpg",
      "source": "MarTech Series",
      "category_within_source": "General",
      "source_domain": "MarTech Series",
      "topics": [
        {
          "topic": "finance",
          "relevance_score": "0.645130"
        },
        {
          "topic": "technology",
          "relevance_score": "0.800582"
        },
        {
          "topic": "manufacturing",
          "relevance_score": "0.732657"
        }
      ],
      "overall_sentiment_score": 0.434751,
      "overall_sentiment_label": "Bullish",
      "ticker_sentiment": [
        {
          "ticker": "CLVT",
          "relevance_score": "1.000000",
          "ticker_sentiment_score": "0.400445",
          "ticker_sentiment_label": "Bullish"
        }
      ]
    },
    {
      "title": "Clarivate's IPfolio Selected by Nissan Motor for Workflow Automation",
      "url": "https://www.marketscreener.com/news/clarivate-s-ipfolio-selected-by-nissan-motor-for-workflow-automation-ce7d50dcdb8bfe2c",
      "time_published": "20251218T091042",
      "authors": [
        "NULL"
      ],
      "summary": "Clarivate's IPfolio has been chosen by Nissan Motor for intellectual property workflow automation. This partnership highlights the demand for specialized solutions to manage complex IP processes within large corporations. The article also provides recent news and financial data on Clarivate Plc.",
      "banner_image": "NULL",
      "source": "marketscreener.com",
      "category_within_source": "General",
      "source_domain": "marketscreener.com",
      "topics": [
        {
          "topic": "earnings",
          "relevance_score": "0.904914"
        },
        {
          "topic": "technology",
          "relevance_score": "0.827862"
        }
      ],
      "overall_sentiment_score": 0.290861,
      "overall_sentiment_label": "Somewhat-Bullish",
      "ticker_sentiment": [
        {
          "ticker": "CLVT",
          "relevance_score": "0.978981",
          "ticker_sentiment_score": "0.273620",
          "ticker_sentiment_label": "Somewhat-Bullish"
        }
      ]
    },
    {
      "title": "Nissan Selects IPfolio from Clarivate",
      "url": "https://www.prnewswire.com/news-releases/nissan-selects-ipfolio-from-clarivate-302643529.html",
      "time_published": "20251218T081042",
      "authors": [
        "NULL"
      ],
      "summary": "Nissan Motor Co., Ltd. has chosen IPfolio, an intellectual property management software from Clarivate Plc, to enhance the efficiency and protection of its intellectual property. This implementation will introduce advanced workflow automation, improved data visibility, and integration capabilities to create a scalable IP management system for Nissan's future needs in the automotive industry. The partnership aims to strengthen Nissan's competitive position by modernizing its IP operations.",
      "banner_image": "NULL",
      "source": "PR Newswire",
      "category_within_source": "General",
      "source_domain": "PR Newswire",
      "topics": [
        {
          "topic": "technology",
          "relevance_score": "0.947955"
        },
        {
          "topic": "finance",
          "relevance_score": "0.730938"
        },
        {
          "topic": "manufacturing",
          "relevance_score": "0.610365"
        }
      ],
      "overall_sentiment_score": 0.437629,
      "overall_sentiment_label": "Bullish",
      "ticker_sentiment": [
        {
          "ticker": "CLVT",
          "relevance_score": "1.000000",
          "ticker_sentiment_score": "0.413121",
          "ticker_sentiment_label": "Bullish"
        }
      ]
    },
    {
      "title": "Nissan Selects IPfolio from Clarivate",
      "url": "https://www.theglobeandmail.com/investing/markets/stocks/NSANY/pressreleases/36683483/nissan-selects-ipfolio-from-clarivate/",
      "time_published": "20251218T081042",
      "authors": [],
      "summary": "Clarivate Plc announced that Nissan Motor Co., Ltd. has chosen its IPfolio intellectual property management software. This system will assist Nissan in more efficiently managing and safeguarding its intellectual property through advanced workflow automation and analytics. The article emphasizes the importance of utilizing advanced technology and data for IP management.",
      "banner_image": null,
      "source": "The Globe and Mail",
      "category_within_source": "General",
      "source_domain": "The Globe and Mail",
      "topics": [
        {
          "topic": "technology",
          "relevance_score": "0.839717"
        }
      ],
      "overall_sentiment_score": 0.349116,
      "overall_sentiment_label": "Somewhat-Bullish",
      "ticker_sentiment": [
        {
          "ticker": "CLVT",
          "relevance_score": "1.000000",
          "ticker_sentiment_score": "0.346801",
          "ticker_sentiment_label": "Somewhat-Bullish"
        }
      ]
    },
    {
      "title": "Morgan Stanley downgrades Clarivate stock to Underweight on growth concerns",
      "url": "https://ng.investing.com/news/analyst-ratings/morgan-stanley-downgrades-clarivate-stock-to-underweight-on-growth-concerns-93CH-2258016",
      "time_published": "20251218T011001",
      "authors": [
        "Investing.com"
      ],
      "summary": "Morgan Stanley downgraded Clarivate Plc (NYSE:CLVT) from Equalweight to Underweight, reducing its price target from $5.00 to $3.00 due to growth concerns. The investment bank cited expectations for flat to low-single-digit growth and limited operating leverage, leading to low-single-digit adjusted EBITDA growth for the information services company. Key headwinds include ongoing funding pressures in pharmaceutical, academic, and government sectors, alongside increased competition from AI.",
      "banner_image": "https://i-invdn-com.investing.com/news/international_newspapers_69x52._800x533_L_1419494241.jpg",
      "source": "Investing.com Nigeria",
      "category_within_source": "General",
      "source_domain": "Investing.com Nigeria",
      "topics": [
        {
          "topic": "earnings",
          "relevance_score": "0.938051"
        },
        {
          "topic": "financial_markets",
          "relevance_score": "0.843934"
        }
      ],
      "overall_sentiment_score": -0.408558,
      "overall_sentiment_label": "Bearish",
      "ticker_sentiment": [
        {
          "ticker": "CLVT",
          "relevance_score": "1.000000",
          "ticker_sentiment_score": "-0.449939",
          "ticker_sentiment_label": "Bearish"
        },
        {
          "ticker": "MS",
          "relevance_score": "0.721122",
          "ticker_sentiment_score": "-0.445383",
          "ticker_sentiment_label": "Bearish"
        }
      ]
    },
    {
      "title": "Clarivate PLC (NYSE:CLVT) Given Consensus Rating of \"Reduce\" by Analysts",
      "url": "https://www.marketbeat.com/instant-alerts/clarivate-plc-nyseclvt-given-consensus-rating-of-reduce-by-analysts-2025-12-17/",
      "time_published": "20251217T141020",
      "authors": [
        "MarketBeat"
      ],
      "summary": "Clarivate PLC (NYSE:CLVT) has received a consensus \"Reduce\" rating from analysts, with an average 12-month price target of $4.425. Key insider transactions include Bar Veinstein selling 309,902 shares and director Kenneth L. Cornick buying 100,000 shares, bringing insider ownership to 23.18%. The stock is currently trading near $3.58, with a market capitalization of $2.36 billion and a negative P/E ratio of -6.27.",
      "banner_image": "https://www.marketbeat.com/logos/clarivate-plc-logo-1200x675.png?v=20210319144346",
      "source": "MarketBeat",
      "category_within_source": "General",
      "source_domain": "MarketBeat",
      "topics": [
        {
          "topic": "earnings",
          "relevance_score": "0.914359"
        },
        {
          "topic": "financial_markets",
          "relevance_score": "0.845972"
        }
      ],
      "overall_sentiment_score": 0.071818,
      "overall_sentiment_label": "Neutral",
      "ticker_sentiment": [
        {
          "ticker": "CLVT",
          "relevance_score": "0.969576",
          "ticker_sentiment_score": "-0.298168",
          "ticker_sentiment_label": "Somewhat-Bearish"
        },
        {
          "ticker": "NVDA",
          "relevance_score": "0.637055",
          "ticker_sentiment_score": "0.220668",
          "ticker_sentiment_label": "Somewhat-Bullish"
        },
        {
          "ticker": "PLTR",
          "relevance_score": "0.629491",
          "ticker_sentiment_score": "0.234490",
          "ticker_sentiment_label": "Somewhat-Bullish"
        }
      ]
    },
    {
      "title": "Morgan Stanley downgrades Clarivate stock to Underweight on growth concerns",
      "url": "https://www.investing.com/news/analyst-ratings/morgan-stanley-downgrades-clarivate-stock-to-underweight-on-growth-concerns-93CH-4412084",
      "time_published": "20251217T101020",
      "authors": [
        "Investing.com"
      ],
      "summary": "Morgan Stanley downgraded Clarivate Plc (NYSE:CLVT) from Equalweight to Underweight, lowering its price target due to expected flat to low-single-digit growth and limited operating leverage. The firm cited headwinds from funding pressures in key sectors and potential competitive challenges from AI, suggesting the stock's current valuation offers little support despite recent positive earnings and raised revenue outlook.",
      "banner_image": "https://i-invdn-com.investing.com/news/international_newspapers_69x52._800x533_L_1419494241.jpg",
      "source": "Investing.com",
      "category_within_source": "General",
      "source_domain": "Investing.com",
      "topics": [
        {
          "topic": "earnings",
          "relevance_score": "0.943071"
        },
        {
          "topic": "financial_markets",
          "relevance_score": "0.841162"
        },
        {
          "topic": "life_sciences",
          "relevance_score": "0.628672"
        },
        {
          "topic": "technology",
          "relevance_score": "0.623179"
        }
      ],
      "overall_sentiment_score": -0.625805,
      "overall_sentiment_label": "Bearish",
      "ticker_sentiment": [
        {
          "ticker": "CLVT",
          "relevance_score": "1.000000",
          "ticker_sentiment_score": "-0.602204",
          "ticker_sentiment_label": "Bearish"
        }
      ]
    },
    {
      "title": "Clarivate (CLVT): Assessing the Valuation After New AI Tools Boost Its Research and IP Platform",
      "url": "https://www.sahmcapital.com/news/content/clarivate-clvt-assessing-the-valuation-after-new-ai-tools-boost-its-research-and-ip-platform-2025-12-16",
      "time_published": "20251217T021021",
      "authors": [
        "Simply Wall St"
      ],
      "summary": "Clarivate (CLVT) has launched new AI-driven tools, the Cortellis Regulatory Intelligence AI Assistant and Derwent Patent Monitor, aiming to enhance research and IP workflows. Despite a recent brief lift in share price, the stock has seen significant declines over the year and five years, yet analysts suggest it is undervalued with a fair value of $4.93. The company's AI strategy is seen as a potential growth driver, though funding cuts and competitor advancements could impact its pricing power and margin recovery.",
      "banner_image": null,
      "source": "Sahm",
      "category_within_source": "General",
      "source_domain": "Sahm",
      "topics": [
        {
          "topic": "technology",
          "relevance_score": "0.842631"
        },
        {
          "topic": "financial_markets",
          "relevance_score": "0.725667"
        },
        {
          "topic": "earnings",
          "relevance_score": "0.621089"
        }
      ],
      "overall_sentiment_score": 0.260897,
      "overall_sentiment_label": "Somewhat-Bullish",
      "ticker_sentiment": [
        {
          "ticker": "CLVT",
          "relevance_score": "0.994208",
          "ticker_sentiment_score": "0.281644",
          "ticker_sentiment_label": "Somewhat-Bullish"
        }
      ]
    },
    {
      "title": "William Blair Affirms Hold Stance as Clarivate Plc (CLVT) Q3 Net Loss Narrows",
      "url": "http://www.msn.com/en-us/money/companies/william-blair-affirms-hold-stance-as-clarivate-plc-clvt-q3-net-loss-narrows/ar-AA1QSFF4?apiversion=v2&domshim=1&noservercache=1&noservertelemetry=1&batchservertelemetry=1&renderwebcomponents=1&wcseo=1",
      "time_published": "20251216T061008",
      "authors": [],
      "summary": "William Blair has reiterated its \"Hold\" rating on Clarivate Plc (CLVT) after the company reported its Q3 2024 results. Clarivate announced a GAAP net loss of $(0.05) per share, an improvement from $(0.38) in the prior year, despite revenues experiencing a slight decline to $643 million, missing analyst estimates. The company's adjusted EBITDA reached $285 million, and it generated $83 million in free cash flow, with management providing a narrowed outlook for the full year 2024.",
      "banner_image": null,
      "source": "MSN",
      "category_within_source": "General",
      "source_domain": "MSN",
      "topics": [
        {
          "topic": "earnings",
          "relevance_score": "0.916706"
        },
        {
          "topic": "financial_markets",
          "relevance_score": "0.724463"
        }
      ],
      "overall_sentiment_score": -0.054056,
      "overall_sentiment_label": "Neutral",
      "ticker_sentiment": [
        {
          "ticker": "CLVT",
          "relevance_score": "0.965923",
          "ticker_sentiment_score": "-0.094838",
          "ticker_sentiment_label": "Neutral"
        }
      ]
    },
    {
      "title": "Scaling AI in IP: Building trust for growth",
      "url": "https://clarivate.com/intellectual-property/blog/ai-in-ip-why-trust-and-scale-are-the-next-big-challenges/",
      "time_published": "20251215T140946",
      "authors": [
        "Arun Hill"
      ],
      "summary": "Artificial intelligence (AI) has become a core capability for intellectual property (IP) professionals, with adoption surging from 57% in 2023 to 85% in 2025. A new survey reveals that trust in AI builds through hands-on use and consistent, defensible outcomes, not just abstract promises. Scaling AI responsibly requires transparent data practices, auditability, and role-specific enablement, as privacy, liability, and explainability remain top challenges.",
      "banner_image": "https://clarivate.com/intellectual-property/wp-content/uploads/sites/5/2025/12/GettyImages-1791597475-scaled.jpg",
      "source": "Clarivate",
      "category_within_source": "General",
      "source_domain": "Clarivate",
      "topics": [
        {
          "topic": "technology",
          "relevance_score": "0.901673"
        },
        {
          "topic": "finance",
          "relevance_score": "0.630827"
        }
      ],
      "overall_sentiment_score": 0.431481,
      "overall_sentiment_label": "Bullish",
      "ticker_sentiment": [
        {
          "ticker": "CLVT",
          "relevance_score": "1.000000",
          "ticker_sentiment_score": "0.425206",
          "ticker_sentiment_label": "Bullish"
        }
      ]
    },
    {
      "title": "Is Clarivate (CLVT) Quietly Recasting Its Moat Through AI\u2011Driven Research Workflows?",
      "url": "https://simplywall.st/stocks/us/commercial-services/nyse-clvt/clarivate/news/is-clarivate-clvt-quietly-recasting-its-moat-through-aidrive",
      "time_published": "20251214T020946",
      "authors": [
        "Sasha Jovanovic"
      ],
      "summary": "Clarivate (CLVT) recently launched AI-driven tools, Cortellis Regulatory Intelligence AI Assistant and Derwent Patent Monitor, to enhance research workflows in life sciences and intellectual property. These innovations aim to strengthen the appeal of its subscription offerings by improving efficiency in accessing regulatory data and reviewing patents. While these AI upgrades support Clarivate's investment narrative, the company still faces risks from faster-moving AI competitors and the need to manage debt while working towards profitability.",
      "banner_image": "https://images.simplywall.st/company/e460db4f-9c9d-48f3-8a69-1d982e0ca778/chart/quote-price",
      "source": "Simply Wall Street",
      "category_within_source": "General",
      "source_domain": "Simply Wall Street",
      "topics": [
        {
          "topic": "technology",
          "relevance_score": "0.845724"
        },
        {
          "topic": "life_sciences",
          "relevance_score": "0.717579"
        },
        {
          "topic": "financial_markets",
          "relevance_score": "0.633356"
        },
        {
          "topic": "finance",
          "relevance_score": "0.626479"
        }
      ],
      "overall_sentiment_score": 0.129925,
      "overall_sentiment_label": "Neutral",
      "ticker_sentiment": [
        {
          "ticker": "CLVT",
          "relevance_score": "1.000000",
          "ticker_sentiment_score": "0.299058",
          "ticker_sentiment_label": "Somewhat-Bullish"
        },
        {
          "ticker": "VRSK",
          "relevance_score": "0.617903",
          "ticker_sentiment_score": "0.047155",
          "ticker_sentiment_label": "Neutral"
        },
        {
          "ticker": "IBM",
          "relevance_score": "0.615804",
          "ticker_sentiment_score": "0.014760",
          "ticker_sentiment_label": "Neutral"
        },
        {
          "ticker": "AVGO",
          "relevance_score": "0.637370",
          "ticker_sentiment_score": "0.113169",
          "ticker_sentiment_label": "Neutral"
        }
      ]
    },
    {
      "title": "Is Clarivate (CLVT) Quietly Recasting Its Moat Through AI\u2011Driven Research Workflows?",
      "url": "https://simplywall.st/stocks/us/commercial-services/nyse-clvt/clarivate/news/is-clarivate-clvt-quietly-recasting-its-moat-through-aidrive/amp",
      "time_published": "20251214T000910",
      "authors": [
        "Simply Wall St"
      ],
      "summary": "Clarivate has introduced new AI-powered tools, including the Cortellis Regulatory Intelligence AI Assistant and Derwent Patent Monitor, to enhance research workflows in life sciences and intellectual property. These innovations aim to strengthen the appeal and stickiness of its subscription offerings by embedding automation and decision support. While these tools support an AI-driven product upgrade catalyst, investors should consider the ongoing challenge of profitability, debt management, and potential competition from rival AI solutions.",
      "banner_image": "NULL",
      "source": "Simply Wall Street",
      "category_within_source": "General",
      "source_domain": "Simply Wall Street",
      "topics": [
        {
          "topic": "earnings",
          "relevance_score": "0.931474"
        },
        {
          "topic": "life_sciences",
          "relevance_score": "0.816264"
        },
        {
          "topic": "technology",
          "relevance_score": "0.800112"
        },
        {
          "topic": "financial_markets",
          "relevance_score": "0.736218"
        }
      ],
      "overall_sentiment_score": 0.409625,
      "overall_sentiment_label": "Bullish",
      "ticker_sentiment": [
        {
          "ticker": "CLVT",
          "relevance_score": "1.000000",
          "ticker_sentiment_score": "0.399025",
          "ticker_sentiment_label": "Bullish"
        }
      ]
    },
    {
      "title": "Norges Bank Purchases Shares of 4,481,984 Clarivate PLC $CLVT",
      "url": "https://www.marketbeat.com/instant-alerts/filing-norges-bank-purchases-shares-of-4481984-clarivate-plc-clvt-2025-12-09/",
      "time_published": "20251210T030910",
      "authors": [
        "MarketBeat"
      ],
      "summary": "Norges Bank acquired 4,481,984 shares of Clarivate PLC (NYSE:CLVT) in the second quarter, valued at approximately $19.27 million, making it a new institutional investor with a 0.67% stake. Insider activity was mixed, with one insider selling shares while a director purchased 100,000 shares, increasing his ownership. Analysts currently rate CLVT as \"Reduce\" with an average target price of $4.90, and the stock is trading near $3.71.",
      "banner_image": "https://www.marketbeat.com/logos/clarivate-plc-logo-1200x675.png?v=20210319144346",
      "source": "MarketBeat",
      "category_within_source": "General",
      "source_domain": "MarketBeat",
      "topics": [
        {
          "topic": "earnings",
          "relevance_score": "0.924782"
        },
        {
          "topic": "financial_markets",
          "relevance_score": "0.819614"
        },
        {
          "topic": "finance",
          "relevance_score": "0.708890"
        },
        {
          "topic": "life_sciences",
          "relevance_score": "0.631389"
        },
        {
          "topic": "technology",
          "relevance_score": "0.646814"
        }
      ],
      "overall_sentiment_score": 0.035785,
      "overall_sentiment_label": "Neutral",
      "ticker_sentiment": [
        {
          "ticker": "CLVT",
          "relevance_score": "1.000000",
          "ticker_sentiment_score": "0.029119",
          "ticker_sentiment_label": "Neutral"
        }
      ]
    },
    {
      "title": "Clarivate (NYSE:CLVT) Shares Down 5.3% - Time to Sell?",
      "url": "https://www.marketbeat.com/instant-alerts/clarivate-nyseclvt-shares-down-53-time-to-sell-2025-12-09/",
      "time_published": "20251210T030910",
      "authors": [
        "MarketBeat"
      ],
      "summary": "Clarivate's (NYSE:CLVT) stock price fell 5.3% to $3.51 during mid-day trading on Tuesday, with trading volume significantly lower than average. Analyst ratings are mixed, with an average \"Reduce\" rating and a target price of $4.90, despite some recent upgrades. Insider activity shows a notable sale by Bar Veinstein and a purchase by director Kenneth L. Cornick.",
      "banner_image": "https://www.marketbeat.com/logos/clarivate-plc-logo-1200x675.png?v=20210319144346",
      "source": "MarketBeat",
      "category_within_source": "General",
      "source_domain": "MarketBeat",
      "topics": [
        {
          "topic": "financial_markets",
          "relevance_score": "1.000000"
        },
        {
          "topic": "earnings",
          "relevance_score": "0.930020"
        },
        {
          "topic": "finance",
          "relevance_score": "0.809979"
        },
        {
          "topic": "life_sciences",
          "relevance_score": "0.628526"
        },
        {
          "topic": "technology",
          "relevance_score": "0.632277"
        }
      ],
      "overall_sentiment_score": -0.215886,
      "overall_sentiment_label": "Somewhat-Bearish",
      "ticker_sentiment": [
        {
          "ticker": "CLVT",
          "relevance_score": "1.000000",
          "ticker_sentiment_score": "-0.246399",
          "ticker_sentiment_label": "Somewhat-Bearish"
        }
      ]
    },
    {
      "title": "1. Prudential Financial Inc. Has $1.76 Million Stock Position in Clarivate PLC $CLVT",
      "url": "https://www.marketbeat.com/instant-alerts/filing-prudential-financial-inc-has-176-million-stock-position-in-clarivate-plc-clvt-2025-12-06/",
      "time_published": "20251210T021008",
      "authors": [
        "MarketBeat"
      ],
      "summary": "Prudential Financial Inc. significantly increased its stake in Clarivate PLC by nearly 3,000% in Q2, acquiring 395,097 additional shares to hold a total of 408,285 shares valued at approximately $1.76 million. Clarivate has also seen considerable insider buying, with Director Kenneth L. Cornick purchasing 500,000 shares for $1.69 million, bringing his total ownership to 775,000 shares. Despite institutional ownership of 85.72%, analysts currently have a \"Reduce\" rating on the stock with a consensus target price of $4.90.",
      "banner_image": "https://www.marketbeat.com/logos/clarivate-plc-logo-1200x675.png?v=20210319144346",
      "source": "MarketBeat",
      "category_within_source": "General",
      "source_domain": "MarketBeat",
      "topics": [
        {
          "topic": "financial_markets",
          "relevance_score": "0.915055"
        },
        {
          "topic": "finance",
          "relevance_score": "0.845915"
        },
        {
          "topic": "earnings",
          "relevance_score": "0.730083"
        },
        {
          "topic": "life_sciences",
          "relevance_score": "0.603190"
        },
        {
          "topic": "technology",
          "relevance_score": "0.608139"
        }
      ],
      "overall_sentiment_score": 0.183884,
      "overall_sentiment_label": "Somewhat-Bullish",
      "ticker_sentiment": [
        {
          "ticker": "CLVT",
          "relevance_score": "1.000000",
          "ticker_sentiment_score": "0.119905",
          "ticker_sentiment_label": "Neutral"
        },
        {
          "ticker": "PRU",
          "relevance_score": "0.727890",
          "ticker_sentiment_score": "0.209369",
          "ticker_sentiment_label": "Somewhat-Bullish"
        },
        {
          "ticker": "BK",
          "relevance_score": "0.635347",
          "ticker_sentiment_score": "0.247203",
          "ticker_sentiment_label": "Somewhat-Bullish"
        }
      ]
    },
    {
      "title": "UPC litigation trends: Tech specialization by Division",
      "url": "https://clarivate.com/intellectual-property/blog/technology-trends-at-the-unified-patent-court/",
      "time_published": "20251208T151020",
      "authors": [
        "Eric Sergheraert"
      ],
      "summary": "An analysis of Unified Patent Court (UPC) litigation data from June 2023 to May 2025 reveals that Electrical engineering and Information and communication technologies (ICT) are driving most disputes. While pharmaceutical litigation appears limited under narrow classifications, a broader view shows its larger influence, particularly with medical devices. The study also highlights varying technical specializations among UPC Local Divisions, which significantly impacts strategic forum choice for IP owners.",
      "banner_image": "https://clarivate.com/intellectual-property/wp-content/uploads/sites/5/2024/03/CL_photo_abstract_132-1.jpg",
      "source": "Clarivate",
      "category_within_source": "General",
      "source_domain": "Clarivate",
      "topics": [
        {
          "topic": "life_sciences",
          "relevance_score": "0.715716"
        },
        {
          "topic": "technology",
          "relevance_score": "0.827053"
        }
      ],
      "overall_sentiment_score": 0.114604,
      "overall_sentiment_label": "Neutral",
      "ticker_sentiment": [
        {
          "ticker": "CLVT",
          "relevance_score": "1.000000",
          "ticker_sentiment_score": "0.108807",
          "ticker_sentiment_label": "Neutral"
        }
      ]
    },
    {
      "title": "Using epidemiology data to forecast markets for pharmas and biotechs",
      "url": "https://clarivate.com/life-sciences-healthcare/blog/forecasting-target-markets-using-epidemiology-data/",
      "time_published": "20251208T151020",
      "authors": [
        "Narendra Parihar",
        "Shyama Ghosh"
      ],
      "summary": "This article details Clarivate's methodology for using epidemiology data to forecast markets for pharmaceutical and biotechnology companies. It emphasizes rigorous literature review, expert analysis, and the leveraging of AI/ML technology to provide precise incidence, prevalence, and drug-treatable population estimates. The goal is to help clients make informed decisions regarding drug research, commercialization, and investment validation.",
      "banner_image": "https://clarivate.com/life-sciences-healthcare/wp-content/uploads/sites/4/2020/06/CL_photo_abstract_076.jpg",
      "source": "Clarivate",
      "category_within_source": "General",
      "source_domain": "Clarivate",
      "topics": [
        {
          "topic": "life_sciences",
          "relevance_score": "0.924985"
        },
        {
          "topic": "financial_markets",
          "relevance_score": "0.638850"
        }
      ],
      "overall_sentiment_score": 0.519857,
      "overall_sentiment_label": "Bullish",
      "ticker_sentiment": [
        {
          "ticker": "CLVT",
          "relevance_score": "1.000000",
          "ticker_sentiment_score": "0.539898",
          "ticker_sentiment_label": "Bullish"
        }
      ]
    },
    {
      "title": "Clarivate (CLVT) Unveils AI-Powered Regulatory Intelligence Tool",
      "url": "https://www.gurufocus.com/news/3233126/clarivate-clvt-unveils-aipowered-regulatory-intelligence-tool",
      "time_published": "20251205T054023",
      "authors": [
        "NULL"
      ],
      "summary": "Clarivate (CLVT) has launched its Cortellis Regulatory Intelligence AI Assistant, an advanced AI-powered tool designed to enhance user capabilities. This new offering, accessible to all Cortellis Regulatory Intelligence subscribers after a beta phase, aims to strengthen Clarivate's position in the technology sector. Despite the innovative product launch, the company faces financial challenges including negative profitability metrics and significant debt, leading to an \"Altman Z-Score\" indicating potential financial distress.",
      "banner_image": "https://static.gurufocus.com/cdn-cgi/image/width=600,quality=100/logos/0C0000BMM2.png?20",
      "source": "GuruFocus",
      "category_within_source": "General",
      "source_domain": "GuruFocus",
      "topics": [
        {
          "topic": "technology",
          "relevance_score": "0.946866"
        },
        {
          "topic": "earnings",
          "relevance_score": "0.802751"
        },
        {
          "topic": "life_sciences",
          "relevance_score": "0.717224"
        },
        {
          "topic": "finance",
          "relevance_score": "0.629046"
        }
      ],
      "overall_sentiment_score": -0.11654,
      "overall_sentiment_label": "Neutral",
      "ticker_sentiment": [
        {
          "ticker": "CLVT",
          "relevance_score": "0.978975",
          "ticker_sentiment_score": "-0.115575",
          "ticker_sentiment_label": "Neutral"
        }
      ]
    },
    {
      "title": "Clarivate (NYSE: CLVT) rolls out Cortellis Regulatory AI Assistant for life sciences",
      "url": "https://www.stocktitan.net/news/CLVT/clarivate-presents-cortellis-regulatory-ai-assistant-to-cut-through-uds5jlk4hqh6.html",
      "time_published": "20251205T034406",
      "authors": [
        "NULL"
      ],
      "summary": "Clarivate (NYSE: CLVT) has launched its Cortellis Regulatory Intelligence AI Assistant, an agentic AI tool for life sciences regulatory teams. This assistant offers instant, cited, context-aware answers, multilingual support, rapid document summarization, and draft-versus-final guidance comparison to streamline regulatory review and decision-making. Developed with customer feedback, it aims to enhance accuracy and workflow efficiency across the product lifecycle for Cortellis Regulatory Intelligence customers.",
      "banner_image": "NULL",
      "source": "Stock Titan",
      "category_within_source": "General",
      "source_domain": "Stock Titan",
      "topics": [
        {
          "topic": "technology",
          "relevance_score": "1.000000"
        },
        {
          "topic": "life_sciences",
          "relevance_score": "0.947528"
        }
      ],
      "overall_sentiment_score": 0.420334,
      "overall_sentiment_label": "Bullish",
      "ticker_sentiment": [
        {
          "ticker": "CLVT",
          "relevance_score": "1.000000",
          "ticker_sentiment_score": "0.404879",
          "ticker_sentiment_label": "Bullish"
        }
      ]
    },
    {
      "title": "Global research collaboration is changing: Key insights from our latest ISI report",
      "url": "https://clarivate.com/academia-government/blog/research-collaboration-in-a-changing-world/",
      "time_published": "20251204T040928",
      "authors": [
        "Jonathan Adams"
      ],
      "summary": "This report from the Institute for Scientific Information (ISI) at Clarivate analyzes trends in global research collaboration, highlighting a shift towards multilateral partnerships and the growing influence of Mainland China. It also examines the challenges facing the U.S. in maintaining its leadership role, emphasizing that collaboration remains crucial for high-impact research. The report uses data from the Web of Science Core Collection and InCites to provide data-driven insights.",
      "banner_image": "https://clarivate.com/academia-government/wp-content/uploads/sites/3/2025/12/GettyImages-1367460917-cropped-2-1.jpg",
      "source": "Clarivate",
      "category_within_source": "General",
      "source_domain": "Clarivate",
      "topics": [
        {
          "topic": "economy_macro",
          "relevance_score": "0.838247"
        },
        {
          "topic": "life_sciences",
          "relevance_score": "0.646831"
        },
        {
          "topic": "technology",
          "relevance_score": "0.639807"
        }
      ],
      "overall_sentiment_score": 0.014681,
      "overall_sentiment_label": "Neutral",
      "ticker_sentiment": [
        {
          "ticker": "CLVT",
          "relevance_score": "0.316845",
          "ticker_sentiment_score": "0.002296",
          "ticker_sentiment_label": "Neutral"
        }
      ]
    },
    {
      "title": "Twelfth Annual \u201cResearch Fronts Report\u201d Highlights Hot and Emerging Fields",
      "url": "https://clarivate.com/academia-government/blog/twelfth-annual-research-fronts-report-highlights-hot-and-emerging-fields/",
      "time_published": "20251204T034406",
      "authors": [
        "Steven Wang"
      ],
      "summary": "Clarivate, in partnership with the Chinese Academy of Sciences (CAS), has released its twelfth annual \"Research Fronts Report,\" identifying 110 \"hot\" and 18 emerging fields in science. The report, based on citation analysis, provides an \"organic\" view of research trends across various disciplines, including clinical medicine, materials science, astronomy, and social sciences. It highlights significant advancements, such as precision therapies for cystic fibrosis and chemical recycling of plastics, while also noting the growing interdisciplinary presence of artificial intelligence.",
      "banner_image": "https://clarivate.com/academia-government/wp-content/uploads/sites/3/2023/06/CL_photo_abstract_131-scaled-1.jpg",
      "source": "Clarivate",
      "category_within_source": "General",
      "source_domain": "Clarivate",
      "topics": [
        {
          "topic": "life_sciences",
          "relevance_score": "0.705155"
        },
        {
          "topic": "technology",
          "relevance_score": "0.842122"
        }
      ],
      "overall_sentiment_score": 0.444232,
      "overall_sentiment_label": "Bullish",
      "ticker_sentiment": [
        {
          "ticker": "CLVT",
          "relevance_score": "1.000000",
          "ticker_sentiment_score": "0.408646",
          "ticker_sentiment_label": "Bullish"
        }
      ]
    },
    {
      "title": "Insider Sell: Bar Veinstein Sells 309,902 Shares of Clarivate PL",
      "url": "https://www.gurufocus.com/news/3231114/insider-sell-bar-veinstein-sells-309902-shares-of-clarivate-plc-clvt",
      "time_published": "20251203T034406",
      "authors": [
        "GuruFocus News"
      ],
      "summary": "Bar Veinstein, President of A&G at Clarivate PLC, sold 309,902 shares of the company on December 1, 2025, reducing his holdings to 848,811 shares. At the time of the transaction, Clarivate PLC's stock traded at $3.74, suggesting it might be a \"Possible Value Trap\" with a price-to-GF-Value ratio of 0.59. This sale contributes to a history of 2 insider sells against 7 insider buys for the company over the past year.",
      "banner_image": "https://static.gurufocus.com/cdn-cgi/image/width=600,quality=100/logos/0C0000BMM2.png?14",
      "source": "GuruFocus",
      "category_within_source": "General",
      "source_domain": "GuruFocus",
      "topics": [
        {
          "topic": "financial_markets",
          "relevance_score": "0.946589"
        },
        {
          "topic": "earnings",
          "relevance_score": "0.836450"
        }
      ],
      "overall_sentiment_score": -0.273875,
      "overall_sentiment_label": "Somewhat-Bearish",
      "ticker_sentiment": [
        {
          "ticker": "CLVT",
          "relevance_score": "1.000000",
          "ticker_sentiment_score": "-0.292399",
          "ticker_sentiment_label": "Somewhat-Bearish"
        }
      ]
    },
    {
      "title": "William Blair Affirms Hold Stance as Clarivate Plc (CLVT) Q3 Net Loss Narrows",
      "url": "https://www.msn.com/en-us/money/companies/william-blair-affirms-hold-stance-as-clarivate-plc-clvt-q3-net-loss-narrows/ar-AA1QSFF4",
      "time_published": "20251122T030938",
      "authors": [
        "NULL"
      ],
      "summary": "William Blair has reaffirmed its \"Hold\" rating on Clarivate Plc (CLVT) after the company reported a narrower net loss in its third quarter. The company posted a net loss of $24.7 million for Q3, compared to a loss of $147.2 million in the prior year, with adjusted earnings meeting expectations and revenue slightly exceeding them. Clarivate also provided revenue guidance for 2024.",
      "banner_image": "NULL",
      "source": "MSN",
      "category_within_source": "General",
      "source_domain": "MSN",
      "topics": [
        {
          "topic": "earnings",
          "relevance_score": "0.944334"
        },
        {
          "topic": "financial_markets",
          "relevance_score": "0.705759"
        }
      ],
      "overall_sentiment_score": 0.240711,
      "overall_sentiment_label": "Somewhat-Bullish",
      "ticker_sentiment": [
        {
          "ticker": "CLVT",
          "relevance_score": "1.000000",
          "ticker_sentiment_score": "0.248882",
          "ticker_sentiment_label": "Somewhat-Bullish"
        }
      ]
    },
    {
      "title": "Clarivate Announces Highly Cited Researchers 2025 List",
      "url": "https://www.prnewswire.com/news-releases/clarivate-announces-highly-cited-researchers-2025-list-302612200.html",
      "time_published": "20251112T030300",
      "authors": [
        "NULL"
      ],
      "summary": "Clarivate Plc has released its Highly Cited Researchers 2025 list, recognizing 6,868 individuals whose work has significantly influenced their fields. The report highlights the global landscape of top research talent, with the U.S. leading, followed by Mainland China and the U.K., and notes a concentration of awards in top countries. The program has evolved with enhanced screening to ensure research integrity and impact.",
      "banner_image": "NULL",
      "source": "PR Newswire",
      "category_within_source": "General",
      "source_domain": "PR Newswire",
      "topics": [
        {
          "topic": "technology",
          "relevance_score": "0.810455"
        }
      ],
      "overall_sentiment_score": 0.444824,
      "overall_sentiment_label": "Bullish",
      "ticker_sentiment": [
        {
          "ticker": "CLVT",
          "relevance_score": "1.000000",
          "ticker_sentiment_score": "0.409874",
          "ticker_sentiment_label": "Bullish"
        }
      ]
    },
    {
      "title": "Fujifilm Selects IPfolio from Clarivate",
      "url": "https://www.prnewswire.com/news-releases/fujifilm-selects-ipfolio-from-clarivate-302605636.html",
      "time_published": "20251106T030000",
      "authors": [
        "NULL"
      ],
      "summary": "FUJIFILM Holdings Corporation has chosen IPfolio, Clarivate's cloud-based intellectual property (IP) management platform, to enhance the efficiency of its IP operations and support business growth across its diverse global businesses. This solution enables Fujifilm to manage its entire IP lifecycle from a single workflow platform, facilitating faster and more efficient IP decisions. By leveraging IPfolio, Fujifilm aims to accelerate the transformation of its IP operations and strategically utilize intellectual property to boost corporate value.",
      "banner_image": "NULL",
      "source": "PR Newswire",
      "category_within_source": "General",
      "source_domain": "PR Newswire",
      "topics": [
        {
          "topic": "technology",
          "relevance_score": "0.826797"
        }
      ],
      "overall_sentiment_score": 0.46677,
      "overall_sentiment_label": "Bullish",
      "ticker_sentiment": [
        {
          "ticker": "CLVT",
          "relevance_score": "1.000000",
          "ticker_sentiment_score": "0.451897",
          "ticker_sentiment_label": "Bullish"
        }
      ]
    },
    {
      "title": "Pulsed field ablation: stunning growth shocks the atrial fibrillation market",
      "url": "https://clarivate.com/life-sciences-healthcare/lp/pulsed-field-ablation-stunning-growth-shocks-the-atrial-fibrillation-market/",
      "time_published": "20251102T112100",
      "authors": [],
      "summary": "Pulsed field ablation (PFA) is projected to dominate the global atrial fibrillation treatment market, capturing over 70% share and exceeding $7 billion by 2028. This rapid ascent reflects its game-changing potential against a disease expected to affect 102 million people globally by 2050. The report from Clarivate analyzes the drivers and companies behind PFA's remarkable growth and its impact on the broader market for atrial fibrillation treatments.",
      "banner_image": null,
      "source": "Clarivate",
      "category_within_source": "General",
      "source_domain": "Clarivate",
      "topics": [
        {
          "topic": "life_sciences",
          "relevance_score": "0.916689"
        }
      ],
      "overall_sentiment_score": 0.310654,
      "overall_sentiment_label": "Somewhat-Bullish",
      "ticker_sentiment": [
        {
          "ticker": "CLVT",
          "relevance_score": "1.000000",
          "ticker_sentiment_score": "0.347916",
          "ticker_sentiment_label": "Somewhat-Bullish"
        }
      ]
    },
    {
      "title": "Clarivate Plc (NYSE:CLVT) Q3 2025 Earnings Call Transcript",
      "url": "https://www.insidermonkey.com/blog/clarivate-plc-nyseclvt-q3-2025-earnings-call-transcript-1637132/",
      "time_published": "20251030T081400",
      "authors": [],
      "summary": "Clarivate Plc (NYSE:CLVT) held its Q3 2025 earnings call, reporting that Q3 revenue was $623 million, essentially flat year-over-year, and a net loss of $28 million. The company emphasized continued progress on its value creation plan, with annual contract value (ACV) improving to 1.6% and renewal rates at 93%. Clarivate also highlighted its investments in AI-powered products across its Academia & Government, Intellectual Property, and Life Science & Health segments, aiming for sustainable organic growth and improved operational efficiency.",
      "banner_image": "https://imonkey-blog.imgix.net/blog/wp-content/uploads/2023/09/29140348/CLVT-insidermonkey-1696010626137.jpg?auto=format&fit=clip&expires=1797033600&width=480&height=269",
      "source": "Insider Monkey",
      "category_within_source": "General",
      "source_domain": "Insider Monkey",
      "topics": [
        {
          "topic": "earnings",
          "relevance_score": "0.903023"
        },
        {
          "topic": "life_sciences",
          "relevance_score": "0.731391"
        },
        {
          "topic": "technology",
          "relevance_score": "0.701309"
        }
      ],
      "overall_sentiment_score": -0.44327,
      "overall_sentiment_label": "Bearish",
      "ticker_sentiment": [
        {
          "ticker": "CLVT",
          "relevance_score": "1.000000",
          "ticker_sentiment_score": "-0.410844",
          "ticker_sentiment_label": "Bearish"
        }
      ]
    },
    {
      "title": "Clarivate (CLVT): Assessing Undervaluation After Recent Share Price Movement - Yahoo",
      "url": "https://uk.finance.yahoo.com/news/clarivate-clvt-assessing-undervaluation-recent-041401900.html",
      "time_published": "20251018T041400",
      "authors": [
        "NULL"
      ],
      "summary": "This article discusses the potential undervaluation of Clarivate (CLVT) after recent share price movements. It likely analyzes financial metrics and market performance to assess whether the company's stock is trading below its intrinsic value, attracting investors looking for undervalued opportunities.",
      "banner_image": "NULL",
      "source": "Yahoo",
      "category_within_source": "General",
      "source_domain": "Yahoo",
      "topics": [
        {
          "topic": "financial_markets",
          "relevance_score": "0.906627"
        },
        {
          "topic": "finance",
          "relevance_score": "0.732404"
        }
      ],
      "overall_sentiment_score": 0.003525,
      "overall_sentiment_label": "Neutral",
      "ticker_sentiment": [
        {
          "ticker": "CLVT",
          "relevance_score": "0.308095",
          "ticker_sentiment_score": "0.016358",
          "ticker_sentiment_label": "Neutral"
        }
      ]
    },
    {
      "title": "Clarivate\u2019s (CLVT) Sell (D-) Rating Reaffirmed at Weiss Ratings - Defense World",
      "url": "https://www.defenseworld.net/2025/10/15/clarivates-clvt-sell-d-rating-reaffirmed-at-weiss-ratings.html",
      "time_published": "20251015T070810",
      "authors": [
        "Defense World Staff"
      ],
      "summary": "Weiss Ratings has reaffirmed Clarivate's (CLVT) Sell (D-) rating. This follows Wolfe Research initiating coverage with a \"peer perform\" rating. Institutional investors have significantly altered their positions in Clarivate, with hedge funds and other institutional investors owning 85.72% of the company's stock.",
      "banner_image": "NULL",
      "source": "Defense World",
      "category_within_source": "General",
      "source_domain": "Defense World",
      "topics": [
        {
          "topic": "earnings",
          "relevance_score": "0.915440"
        },
        {
          "topic": "financial_markets",
          "relevance_score": "0.849255"
        },
        {
          "topic": "finance",
          "relevance_score": "0.729205"
        },
        {
          "topic": "life_sciences",
          "relevance_score": "0.400337"
        },
        {
          "topic": "technology",
          "relevance_score": "0.310948"
        }
      ],
      "overall_sentiment_score": 0.007405,
      "overall_sentiment_label": "Neutral",
      "ticker_sentiment": [
        {
          "ticker": "CLVT",
          "relevance_score": "0.331568",
          "ticker_sentiment_score": "0.021306",
          "ticker_sentiment_label": "Neutral"
        }
      ]
    },
    {
      "title": "Sinopec Group Selects Clarivate for Impactful Research and Innovation",
      "url": "https://www.prnewswire.com/news-releases/sinopec-group-selects-clarivate-for-impactful-research-and-innovation-302538781.html",
      "time_published": "20250827T030000",
      "authors": [],
      "summary": "Clarivate Plc has signed agreements to provide Sinopec Group with its academic research and intellectual property solutions, including Web of Science and incoPat. This partnership aims to empower Sinopec Group's research and development goals, particularly in low-carbon energy and environment-friendly materials, by providing enriched data, insights, and expert services for innovation. The collaboration builds on existing relationships, with Sinopec already utilizing other Clarivate solutions.",
      "banner_image": null,
      "source": "PR Newswire",
      "category_within_source": "General",
      "source_domain": "PR Newswire",
      "topics": [
        {
          "topic": "technology",
          "relevance_score": "0.817612"
        },
        {
          "topic": "energy_transportation",
          "relevance_score": "0.729487"
        },
        {
          "topic": "finance",
          "relevance_score": "0.640980"
        }
      ],
      "overall_sentiment_score": 0.421849,
      "overall_sentiment_label": "Bullish",
      "ticker_sentiment": [
        {
          "ticker": "CLVT",
          "relevance_score": "1.000000",
          "ticker_sentiment_score": "0.444028",
          "ticker_sentiment_label": "Bullish"
        }
      ]
    },
    {
      "title": "Is There An Opportunity With Clarivate Plc's (NYSE:CLVT) 32% Undervaluation?",
      "url": "https://simplywall.st/stocks/us/commercial-services/nyse-clvt/clarivate/news/is-there-an-opportunity-with-clarivate-plcs-nyseclvt-32-unde",
      "time_published": "20250726T000000",
      "authors": [
        "Simply Wall St"
      ],
      "summary": "This article analyzes Clarivate Plc (NYSE:CLVT) and concludes that it is potentially 32% undervalued based on a Discounted Cash Flow (DCF) model, with an estimated fair value of US$6.63 against a current share price of US$4.53. The analysis provides a detailed breakdown of the DCF calculation, including future cash flow forecasts and terminal value, while also highlighting important assumptions and risks associated with the valuation. Investors are encouraged to consider these factors, alongside other fundamental indicators, before making investment decisions.",
      "banner_image": null,
      "source": "Simply Wall Street",
      "category_within_source": "General",
      "source_domain": "Simply Wall Street",
      "topics": [
        {
          "topic": "earnings",
          "relevance_score": "0.935836"
        },
        {
          "topic": "financial_markets",
          "relevance_score": "0.828217"
        },
        {
          "topic": "finance",
          "relevance_score": "0.728639"
        }
      ],
      "overall_sentiment_score": 0.453809,
      "overall_sentiment_label": "Bullish",
      "ticker_sentiment": [
        {
          "ticker": "CLVT",
          "relevance_score": "1.000000",
          "ticker_sentiment_score": "0.462101",
          "ticker_sentiment_label": "Bullish"
        }
      ]
    },
    {
      "title": "At US$4.40, Is Clarivate Plc (NYSE:CLVT) Worth Looking At Closely?",
      "url": "https://simplywall.st/stocks/us/commercial-services/nyse-clvt/clarivate/news/at-us440-is-clarivate-plc-nyseclvt-worth-looking-at-closely",
      "time_published": "20250708T000000",
      "authors": [
        "Simply Wall St"
      ],
      "summary": "Clarivate Plc (NYSE:CLVT) has seen a recent price hike, making it a potential bargain as its intrinsic value is estimated at $6.02 compared to its current trading price of US$4.40. The company shows strong future growth potential with expected profit increases of 93% over the next couple of years, suggesting higher cash flow and a stronger share valuation. Investors, both current and potential, may find Clarivate an attractive option due to its undervaluation and positive outlook, though its stock price volatility should be considered.",
      "banner_image": null,
      "source": "Simply Wall Street",
      "category_within_source": "General",
      "source_domain": "Simply Wall Street",
      "topics": [
        {
          "topic": "earnings",
          "relevance_score": "0.922771"
        },
        {
          "topic": "financial_markets",
          "relevance_score": "0.811160"
        }
      ],
      "overall_sentiment_score": 0.41044,
      "overall_sentiment_label": "Bullish",
      "ticker_sentiment": [
        {
          "ticker": "CLVT",
          "relevance_score": "1.000000",
          "ticker_sentiment_score": "0.417984",
          "ticker_sentiment_label": "Bullish"
        }
      ]
    },
    {
      "title": "Clarivate Reports Fourth Quarter and Full Year 2024 Results",
      "url": "https://www.prnewswire.com/news-releases/clarivate-reports-fourth-quarter-and-full-year-2024-results-302379625.html",
      "time_published": "20250219T060000",
      "authors": [],
      "summary": "Clarivate reported its fourth quarter and full year 2024 results, showing a decrease in total revenue but an improvement in net loss compared to the previous year. The company announced initiatives to transition to subscription-based revenues, launch new product innovations, and conduct a review of strategic alternatives including potential divestitures. Clarivate also provided its 2025 outlook, highlighting a focus on recurring organic revenue growth and cost management.",
      "banner_image": null,
      "source": "PR Newswire",
      "category_within_source": "General",
      "source_domain": "PR Newswire",
      "topics": [
        {
          "topic": "earnings",
          "relevance_score": "0.945811"
        },
        {
          "topic": "finance",
          "relevance_score": "0.726575"
        }
      ],
      "overall_sentiment_score": 0.098729,
      "overall_sentiment_label": "Neutral",
      "ticker_sentiment": [
        {
          "ticker": "CLVT",
          "relevance_score": "1.000000",
          "ticker_sentiment_score": "0.064332",
          "ticker_sentiment_label": "Neutral"
        }
      ]
    },
    {
      "title": "Clarivate Reveals Highly Cited Researchers 2024 List",
      "url": "https://www.prnewswire.com/news-releases/clarivate-reveals-highly-cited-researchers-2024-list-302309607.html",
      "time_published": "20241119T030000",
      "authors": [],
      "summary": "Clarivate Plc announced its 2024 list of Highly Cited Researchers, recognizing 6,636 influential individuals globally. The list highlights a shift in research influence with significant gains for Mainland China and Hong Kong SAR, while the United States' share gradually declined. Clarivate emphasizes research integrity through enhanced selection processes addressing publication and citation manipulation.",
      "banner_image": null,
      "source": "PR Newswire",
      "category_within_source": "General",
      "source_domain": "PR Newswire",
      "topics": [
        {
          "topic": "life_sciences",
          "relevance_score": "0.740368"
        },
        {
          "topic": "finance",
          "relevance_score": "0.628655"
        },
        {
          "topic": "technology",
          "relevance_score": "0.628219"
        }
      ],
      "overall_sentiment_score": 0.416418,
      "overall_sentiment_label": "Bullish",
      "ticker_sentiment": [
        {
          "ticker": "CLVT",
          "relevance_score": "1.000000",
          "ticker_sentiment_score": "0.442594",
          "ticker_sentiment_label": "Bullish"
        }
      ]
    },
    {
      "title": "Clarivate reveals Highly Cited Researchers",
      "url": "https://www.researchinformation.info/news/clarivate-reveals-highly-cited-researchers/",
      "time_published": "20241119T000000",
      "authors": [],
      "summary": "Clarivate Plc has released its 2024 list of Highly Cited Researchers, recognizing 6,636 influential researchers across 59 nations and regions based on Web of Science data and expert analysis. The report highlights a shift in global research influence, with Mainland China and Hong Kong making significant gains while the United States' share gradually declined. Clarivate emphasizes its commitment to research integrity by continually refining its evaluation processes to address issues like hyper-authorship and anomalous citation patterns.",
      "banner_image": "https://www.researchinformation.info/sites/default/files/styles/16_9_medium/public/2024-11/Clarivate-Highly-Cited-Researchers.jpg?h=a2dbe11f&itok=5Cykc5Xl",
      "source": "Research Information",
      "category_within_source": "General",
      "source_domain": "Research Information",
      "topics": [
        {
          "topic": "life_sciences",
          "relevance_score": "0.722198"
        },
        {
          "topic": "technology",
          "relevance_score": "0.843435"
        }
      ],
      "overall_sentiment_score": 0.116241,
      "overall_sentiment_label": "Neutral",
      "ticker_sentiment": [
        {
          "ticker": "CLVT",
          "relevance_score": "0.309920",
          "ticker_sentiment_score": "0.044199",
          "ticker_sentiment_label": "Neutral"
        },
        {
          "ticker": "MSFT",
          "relevance_score": "0.600830",
          "ticker_sentiment_score": "0.202636",
          "ticker_sentiment_label": "Somewhat-Bullish"
        }
      ]
    },
    {
      "title": "Here's Why Clarivate (NYSE:CLVT) Has A Meaningful Debt Burden",
      "url": "https://www.sahmcapital.com/news/content/heres-why-clarivate-nyseclvt-has-a-meaningful-debt-burden-2024-09-27",
      "time_published": "20240927T201200",
      "authors": [
        "Simply Wall St"
      ],
      "summary": "Clarivate Plc (NYSE:CLVT) carries a significant debt burden, with net debt around US$4.26 billion against a market capitalization of US$4.84 billion. The company's interest cover ratio of 0.94 times raises concerns despite converting EBIT to free cash flow effectively. While debt can boost returns, shareholders should be cautious given the high leverage and potential for dilution.",
      "banner_image": null,
      "source": "Sahm",
      "category_within_source": "General",
      "source_domain": "Sahm",
      "topics": [
        {
          "topic": "finance",
          "relevance_score": "0.928366"
        },
        {
          "topic": "earnings",
          "relevance_score": "0.830435"
        }
      ],
      "overall_sentiment_score": -0.255673,
      "overall_sentiment_label": "Somewhat-Bearish",
      "ticker_sentiment": [
        {
          "ticker": "CLVT",
          "relevance_score": "1.000000",
          "ticker_sentiment_score": "-0.265753",
          "ticker_sentiment_label": "Somewhat-Bearish"
        }
      ]
    },
    {
      "title": "Konica Minolta Named Among Top 100 Global Innovators 2024 by Clarivate for the Third Consecutive Year",
      "url": "https://www.konicaminolta.com/global-en/newsroom/2024/0315-01-01.html",
      "time_published": "20240315T000000",
      "authors": [
        "NULL"
      ],
      "summary": "Konica Minolta has been recognized by Clarivate as one of the Top 100 Global Innovators for the third consecutive year. This recognition highlights Konica Minolta's commitment to solving social issues through intellectual property and strategic investments in innovation. The company emphasizes leveraging its intangible assets to foster co-creation with customers and enhance corporate value.",
      "banner_image": "NULL",
      "source": "Konica Minolta",
      "category_within_source": "General",
      "source_domain": "Konica Minolta",
      "topics": [
        {
          "topic": "technology",
          "relevance_score": "0.805901"
        }
      ],
      "overall_sentiment_score": 0.540845,
      "overall_sentiment_label": "Bullish",
      "ticker_sentiment": [
        {
          "ticker": "CLVT",
          "relevance_score": "0.911621",
          "ticker_sentiment_score": "0.538084",
          "ticker_sentiment_label": "Bullish"
        }
      ]
    },
    {
      "title": "Clarivate Awarded USPTO Award for AI Design Image Search Tool",
      "url": "https://clarivate.com/intellectual-property/blog/clarivate-awarded-uspto-award-for-designs-image-search-ai-designvision/",
      "time_published": "20240313T000000",
      "authors": [],
      "summary": "Clarivate has been awarded a contract by the USPTO for its AI Design Image Search Tool, DesignVision. This tool will significantly enhance the capabilities of US examiners working on Design Patent applications by using reverse image search AI to quickly identify relevant prior art from over 69 global registers and 80 million images. The technology is already utilized by other IP offices globally and is also available to law firms and corporations through various Clarivate offerings.",
      "banner_image": null,
      "source": "Clarivate",
      "category_within_source": "General",
      "source_domain": "Clarivate",
      "topics": [
        {
          "topic": "technology",
          "relevance_score": "0.800802"
        }
      ],
      "overall_sentiment_score": 0.456144,
      "overall_sentiment_label": "Bullish",
      "ticker_sentiment": [
        {
          "ticker": "CLVT",
          "relevance_score": "1.000000",
          "ticker_sentiment_score": "0.490994",
          "ticker_sentiment_label": "Bullish"
        }
      ]
    },
    {
      "title": "NEC named to list of Top 100 Global Innovators\u2122 by Clarivate for 13th consecutive year: Press Releases",
      "url": "https://www.nec.com/en/press/202403/global_20240307_01.html",
      "time_published": "20240307T000000",
      "authors": [],
      "summary": "NEC Corporation (TSE: 6701) has been recognized by Clarivate Plc. as one of the Top 100 Global Innovators\u2122 for the 13th consecutive year, an achievement attained by only 18 organizations worldwide. Clarivate, a major database company, evaluates companies based on factors such as Influence, Success, Investment, and Rarity, requiring at least 100 patent filings in the last five years. NEC continues to leverage its intellectual property for growth and co-creation, emphasizing its commitment to creating new social value.",
      "banner_image": null,
      "source": "NEC Global",
      "category_within_source": "General",
      "source_domain": "NEC Global",
      "topics": [
        {
          "topic": "technology",
          "relevance_score": "0.938057"
        },
        {
          "topic": "finance",
          "relevance_score": "0.746710"
        }
      ],
      "overall_sentiment_score": 0.405203,
      "overall_sentiment_label": "Bullish",
      "ticker_sentiment": [
        {
          "ticker": "CLVT",
          "relevance_score": "1.000000",
          "ticker_sentiment_score": "0.416981",
          "ticker_sentiment_label": "Bullish"
        }
      ]
    },
    {
      "title": "Nidec Receives \u201cClarivate Top 100 Global Innovator 2024\u201d Award",
      "url": "https://www.nidec.com/en/product/news/2024/news0306-01/",
      "time_published": "20240306T000000",
      "authors": [],
      "summary": "Nidec Corporation announced it has been selected by Clarivate Plc as a \"Clarivate Top 100 Global Innovator 2024\" for the second consecutive year. Clarivate recognizes organizations that are leading global innovation based on their intellectual property analysis. Nidec was recognized for its active engagement in building an internationally competitive IP portfolio and developing products that address social issues related to SDGs.",
      "banner_image": null,
      "source": "Nidec",
      "category_within_source": "General",
      "source_domain": "Nidec",
      "topics": [
        {
          "topic": "manufacturing",
          "relevance_score": "0.915713"
        },
        {
          "topic": "technology",
          "relevance_score": "0.842378"
        }
      ],
      "overall_sentiment_score": 0.415253,
      "overall_sentiment_label": "Bullish",
      "ticker_sentiment": [
        {
          "ticker": "CLVT",
          "relevance_score": "1.000000",
          "ticker_sentiment_score": "0.441060",
          "ticker_sentiment_label": "Bullish"
        }
      ]
    },
    {
      "title": "Epson Ranked Fifth among Clarivate Top 100 Global Innovators (March 6, 2024)",
      "url": "https://corporate.epson/en/news/2024/240306.html",
      "time_published": "20240306T000000",
      "authors": [],
      "summary": "Seiko Epson Corporation has been ranked fifth in the Clarivate Top 100 Global Innovators 2024, marking its eleventh appearance on the prestigious list. This recognition highlights Epson's commitment to continuous innovation and its philosophy of using efficient, compact, and precise innovation to address societal issues and achieve corporate growth, with intellectual property being a foundational pillar of its sustainable management.",
      "banner_image": null,
      "source": "Epson Corporate",
      "category_within_source": "General",
      "source_domain": "Epson Corporate",
      "topics": [
        {
          "topic": "manufacturing",
          "relevance_score": "0.935713"
        },
        {
          "topic": "technology",
          "relevance_score": "0.831570"
        }
      ],
      "overall_sentiment_score": 0.504729,
      "overall_sentiment_label": "Bullish",
      "ticker_sentiment": [
        {
          "ticker": "CLVT",
          "relevance_score": "1.000000",
          "ticker_sentiment_score": "0.512243",
          "ticker_sentiment_label": "Bullish"
        }
      ]
    },
    {
      "title": "Exor takes 10% stake in data provider Clarivate, can rise to 17.5%",
      "url": "https://www.reuters.com/markets/deals/exor-announces-10-stake-data-provider-clarivate-can-rise-175-2024-03-04/",
      "time_published": "20240304T025100",
      "authors": [
        "Reuters"
      ],
      "summary": "Italy's Agnelli family investment arm Exor has acquired a 10.1% stake in information services provider Clarivate, with the potential to increase its holding to 17.5%. This move marks Exor as a long-term investor in Clarivate, aiming for a board seat for its COO. The investment is part of Exor's strategy to deploy capital raised from a recent sale, making them the second-largest investor in Clarivate.",
      "banner_image": "https://www.reuters.com/resizer/v2/https%3A%2F%2Fcloudfront-us-east-2.images.arcpublishing.com%2Freuters%2FJY7W2O2GKNISHDN5R5H5E27SXI.JPG?auth=d991b3abf29633dd346b0a88fd9cfebfc10e1654a93880590a3692d77d704289&width=1200&height=630&unsharp=true&upsize=true",
      "source": "Reuters",
      "category_within_source": "General",
      "source_domain": "Reuters",
      "topics": [
        {
          "topic": "mergers_and_acquisitions",
          "relevance_score": "0.901956"
        },
        {
          "topic": "finance",
          "relevance_score": "0.747701"
        },
        {
          "topic": "life_sciences",
          "relevance_score": "0.611391"
        },
        {
          "topic": "manufacturing",
          "relevance_score": "0.623250"
        },
        {
          "topic": "technology",
          "relevance_score": "0.633051"
        }
      ],
      "overall_sentiment_score": 0.484793,
      "overall_sentiment_label": "Bullish",
      "ticker_sentiment": [
        {
          "ticker": "CLVT",
          "relevance_score": "1.000000",
          "ticker_sentiment_score": "0.451731",
          "ticker_sentiment_label": "Bullish"
        }
      ]
    },
    {
      "title": "Clarivate Reveals World's Influential Researchers in Highly Cited Researchers 2023 List",
      "url": "https://www.stocktitan.net/news/CLVT/clarivate-reveals-world-apos-s-influential-researchers-in-highly-x3w6l18nnndt.html",
      "time_published": "20231115T030000",
      "authors": [],
      "summary": "Clarivate Plc announced its 2023 Highly Cited Researchers list, recognizing 6,849 influential researchers globally whose work has significantly impacted their fields. The list, compiled by the Institute for Scientific Information (ISI)\u2122, highlights a concentration of talent with over 80% of researchers based in 10 countries/regions, and notes a shift in global research influence with Mainland China doubling its share since 2018. This year's selection process included enhanced qualitative filters to ensure research integrity.",
      "banner_image": null,
      "source": "Stock Titan",
      "category_within_source": "General",
      "source_domain": "Stock Titan",
      "topics": [
        {
          "topic": "finance",
          "relevance_score": "0.818599"
        },
        {
          "topic": "technology",
          "relevance_score": "0.744154"
        },
        {
          "topic": "life_sciences",
          "relevance_score": "0.633955"
        }
      ],
      "overall_sentiment_score": 0.348197,
      "overall_sentiment_label": "Somewhat-Bullish",
      "ticker_sentiment": [
        {
          "ticker": "CLVT",
          "relevance_score": "1.000000",
          "ticker_sentiment_score": "0.318807",
          "ticker_sentiment_label": "Somewhat-Bullish"
        }
      ]
    },
    {
      "title": "2 Japanese on British firm's list of Nobel-class researchers",
      "url": "https://english.kyodonews.net/articles/-/43535",
      "time_published": "20230923T110000",
      "authors": [
        "KYODO NEWS"
      ],
      "summary": "Masashi Yanagisawa and Kazunori Kataoka, two Japanese researchers, have been included in a British research company's list of individuals with Nobel Prize-class achievements. Clarivate Plc identified them based on the significant number of citations their scientific papers received. Yanagisawa was recognized for his discovery of orexin and its impact on sleep disorders, while Kataoka was noted for his development of supramolecular material for targeted drug and gene delivery, aiding cancer treatment.",
      "banner_image": null,
      "source": "Japan Wire by KYODO NEWS",
      "category_within_source": "General",
      "source_domain": "Japan Wire by KYODO NEWS",
      "topics": [
        {
          "topic": "life_sciences",
          "relevance_score": "0.945693"
        },
        {
          "topic": "technology",
          "relevance_score": "0.602143"
        }
      ],
      "overall_sentiment_score": 0.310563,
      "overall_sentiment_label": "Somewhat-Bullish",
      "ticker_sentiment": [
        {
          "ticker": "CLVT",
          "relevance_score": "1.000000",
          "ticker_sentiment_score": "0.337904",
          "ticker_sentiment_label": "Somewhat-Bullish"
        }
      ]
    },
    {
      "title": "Clarivate Unveils Citation Laureates 2023 \u2013 Annual List of Researchers of Nobel Class",
      "url": "https://clarivate.com/news/clarivate-unveils-citation-laureates-2023-annual-list-of-researchers-of-nobel-class/",
      "time_published": "20230919T000000",
      "authors": [],
      "summary": "Clarivate Plc announced its 2023 Citation Laureates, identifying 23 world-class researchers whose work is deemed Nobel-class based on citation analysis. These individuals have made significant contributions across diverse fields such as cancer treatment, genomics, spintronics, and economics. The Institute for Scientific Information at Clarivate has successfully identified 71 Nobel laureates prior to their recognition since 2002.",
      "banner_image": null,
      "source": "Clarivate",
      "category_within_source": "General",
      "source_domain": "Clarivate",
      "topics": [
        {
          "topic": "life_sciences",
          "relevance_score": "0.735118"
        },
        {
          "topic": "technology",
          "relevance_score": "0.639976"
        }
      ],
      "overall_sentiment_score": 0.492727,
      "overall_sentiment_label": "Bullish",
      "ticker_sentiment": [
        {
          "ticker": "CLVT",
          "relevance_score": "1.000000",
          "ticker_sentiment_score": "0.481920",
          "ticker_sentiment_label": "Bullish"
        }
      ]
    },
    {
      "title": "Clarivate Enriches Web of Science Platform with Integration of ProQuest Dissertations and Theses Global",
      "url": "https://clarivate.com/news/clarivate-enriches-web-of-science-platform-with-integration-of-proquest-dissertations-and-theses-global/",
      "time_published": "20230713T000000",
      "authors": [],
      "summary": "Clarivate Plc announced the integration of ProQuest Dissertations & Theses Global with its Web of Science platform, creating the ProQuest Dissertations & Theses Citation Index. This integration provides researchers with access to over 5.5 million global dissertations and theses, streamlining the research process by offering multidisciplinary early career scholarship alongside other scholarly sources in a single platform. The enhancement aims to improve literature reviews, enable discovery of emerging trends, and support academic advancement.",
      "banner_image": null,
      "source": "Clarivate",
      "category_within_source": "General",
      "source_domain": "Clarivate",
      "topics": [
        {
          "topic": "technology",
          "relevance_score": "0.803182"
        }
      ],
      "overall_sentiment_score": 0.438035,
      "overall_sentiment_label": "Bullish",
      "ticker_sentiment": [
        {
          "ticker": "CLVT",
          "relevance_score": "1.000000",
          "ticker_sentiment_score": "0.435899",
          "ticker_sentiment_label": "Bullish"
        }
      ]
    }
  ]
}